Meitar and Cooley advised Gamida Cell on the offering, and Davis Polk advised the underwriter. Gamida Cell Ltd. announced the $23 million SEC-registered follow-on offering of...
You must be a Standard 1 Year member to access this content.
K&L Gates advised AVITA, and Davis Polk advised the sales agent for the offering. AVITA Medical, Inc. announced the establishment of an SEC-registered at-the-market program of...
You must be a Standard 1 Year member to access this content.
NautaDutilh and Kirkland & Ellis advised InflaRx on the offering, and Davis Polk advised the representative of the underwriters involved. InflaRx N.V. announced a public offering...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler, DLA Piper and A&L Goodbody advised Medtronic, while Davis Polk advised the representatives of the several underwriters. Medtronic Global Holdings S.C.A. issued $1 billion...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Intercept Pharmaceuticals on the offering, and Davis Polk advised the sales agent involved. Intercept Pharmaceuticals, Inc. announced the SEC-registered at-the-market offering of its...
You must be a Standard 1 Year member to access this content.
Skadden advised Trimble, and Davis Polk advised the representatives of the several underwriters. Trimble Inc. announced an SEC-registered offering of $800 million aggregate principal amount of...
You must be a Standard 1 Year member to access this content.
Skadden advised Stanley Black & Decker, and Davis Polk advised the joint book-running managers and representatives of the underwriters on the offering. Stanley Black & Decker,...
You must be a Standard 1 Year member to access this content.
Davis Polk served as legal advisor to Ankura, and Squire Patton Boggs served as legal advisor to MVB Financial Corp. Ankura Consulting Group, LLC announced that it...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Eli Lilly, and Davis Polk advised the joint book-running managers for the offering. Eli Lilly and Company announced a registered offering of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins is advising Revolution Medicines on the offering, and Davis Polk is advising the underwriters involved. Revolution Medicines, Inc. (Nasdaq: RVMD) has announced the...
You must be a Standard 1 Year member to access this content.
NautaDutilh and Davis Polk advised CureVac on the offering, while Latham & Watkins advised the underwriters involved. CureVac N.V. announced the pricing of 27,027,028 common shares...
You must be a Standard 1 Year member to access this content.
Davis Polk and Homburger advised ADC Therapeutics, while Cooley and Lenz & Staehelin advised the underwriter. ADC Therapeutics SA announced a registered secondary offering of 12,000,000...
You must be a Standard 1 Year member to access this content.
